Thirumathyam R, Richter EA, van Hall G, Andersen NR, et al. Empagliflozin improves beta cell function independently of relief of glucotoxicity in patients with type 2 diabetes: results from a randomised cross-over study with insulin as comparator. Diabetologia 2025 Dec 9. doi: 10.1007/s00125-025-06616.
PMID: 41366535